RS62887B1 - Triciklična benzoksaborol jedinjenja i njihove upotrebe - Google Patents

Triciklična benzoksaborol jedinjenja i njihove upotrebe

Info

Publication number
RS62887B1
RS62887B1 RS20220108A RSP20220108A RS62887B1 RS 62887 B1 RS62887 B1 RS 62887B1 RS 20220108 A RS20220108 A RS 20220108A RS P20220108 A RSP20220108 A RS P20220108A RS 62887 B1 RS62887 B1 RS 62887B1
Authority
RS
Serbia
Prior art keywords
benzoxaborole compounds
tricyclic benzoxaborole
tricyclic
compounds
benzoxaborole
Prior art date
Application number
RS20220108A
Other languages
English (en)
Inventor
M R K Alley (Dickon)
Vincent S Hernandez
Jacob J Plattner
Xianfeng Li
David Barros-Aguirre
Ilaria Giordano
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd, Anacor Pharmaceuticals Inc filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of RS62887B1 publication Critical patent/RS62887B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
RS20220108A 2013-08-09 2014-08-08 Triciklična benzoksaborol jedinjenja i njihove upotrebe RS62887B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361864496P 2013-08-09 2013-08-09
US201361918976P 2013-12-20 2013-12-20
PCT/US2014/050370 WO2015021396A2 (en) 2013-08-09 2014-08-08 Tricyclic benzoxaborole compounds and uses thereof
EP14834292.6A EP3030519B1 (en) 2013-08-09 2014-08-08 Tricyclic benzoxaborole compounds and uses thereof

Publications (1)

Publication Number Publication Date
RS62887B1 true RS62887B1 (sr) 2022-03-31

Family

ID=52462052

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20220108A RS62887B1 (sr) 2013-08-09 2014-08-08 Triciklična benzoksaborol jedinjenja i njihove upotrebe

Country Status (35)

Country Link
US (5) US20160251380A1 (sr)
EP (2) EP3030519B1 (sr)
JP (2) JP6499175B2 (sr)
KR (1) KR102093783B1 (sr)
CN (2) CN110003253B (sr)
AP (1) AP2016009046A0 (sr)
AU (2) AU2014305792C1 (sr)
BR (1) BR112016002651B1 (sr)
CA (1) CA2919888C (sr)
CL (1) CL2016000313A1 (sr)
CR (1) CR20160064A (sr)
CY (1) CY1125030T1 (sr)
DK (1) DK3030519T3 (sr)
DO (1) DOP2016000045A (sr)
EA (1) EA032844B1 (sr)
ES (1) ES2905413T3 (sr)
HK (1) HK1219939A1 (sr)
HR (1) HRP20220384T1 (sr)
HU (1) HUE057365T2 (sr)
IL (1) IL243874B (sr)
LT (1) LT3030519T (sr)
MX (1) MX2016001732A (sr)
MY (1) MY175823A (sr)
NZ (1) NZ716350A (sr)
PE (1) PE20160752A1 (sr)
PH (1) PH12016500234A1 (sr)
PL (1) PL3030519T3 (sr)
PT (1) PT3030519T (sr)
RS (1) RS62887B1 (sr)
SA (1) SA516370551B1 (sr)
SG (2) SG11201600787PA (sr)
SI (1) SI3030519T1 (sr)
UA (1) UA116908C2 (sr)
WO (1) WO2015021396A2 (sr)
ZA (1) ZA201600792B (sr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094961A1 (es) * 2013-03-15 2015-09-09 Lilly Co Eli 1-hidroxi-benzooxaboroles como agentes antiparasitarios
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
ES2905413T3 (es) * 2013-08-09 2022-04-08 Glaxosmithkline Ip No 2 Ltd Compuestos tricíclicos de benzoxaborol y usos de los mismos
ES2732465T3 (es) 2014-07-01 2019-11-22 Daiichi Sankyo Co Ltd Benzoxaboroles tricíclicos como agentes antibacterianos
MA41495A (fr) 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations
EP3455227A1 (en) 2016-05-12 2019-03-20 Anacor Pharmaceuticals, Inc Oxaborole esters and uses thereof
CN109387594B (zh) * 2017-08-08 2021-01-19 武汉武药科技有限公司 一种分离和分析贝达喹啉光学异构体的方法
PL3737685T3 (pl) * 2018-01-09 2023-10-02 Halcyon Labs Private Limited Sposób wytwarzania kryzaborolu i jego związków pośrednich
WO2021257466A1 (en) * 2020-06-15 2021-12-23 The Global Alliance For Tb Drug Development, Inc. Combination antibacterial composition and method for antibacterial therapy
CN111606850B (zh) * 2020-07-07 2023-07-25 安徽贝克生物制药有限公司 贝达喹啉及其中间体的制备方法
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
CA3239096A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
CA3239097A1 (en) * 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4967997A (en) 1996-12-02 1998-06-29 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
CA2597982C (en) * 2005-02-16 2014-07-08 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US7919422B2 (en) 2005-03-08 2011-04-05 Agency For Science, Technology And Research Chiral bisoxazoline catalysts
CN101505603A (zh) * 2005-12-30 2009-08-12 安纳考尔医药公司 含硼的小分子
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
EP2378886A4 (en) 2008-12-17 2012-08-29 Anacor Pharmaceuticals Inc (S) -3-Aminomethyl-7- (3-hydroxypropoxy) -3H-benzo [c] [1,2] oxaborole-1-OL-POLYMORPHS
US9243003B2 (en) * 2010-04-07 2016-01-26 Glaxosmithkline Llc Process for preparing benzoxaboroles
JP5952280B2 (ja) * 2010-09-07 2016-07-13 アナコール ファーマシューティカルズ，インコーポレーテッド 細菌感染治療用のベンゾオキサボロール誘導体
EP2793901A1 (en) * 2011-12-22 2014-10-29 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
ES2905413T3 (es) 2013-08-09 2022-04-08 Glaxosmithkline Ip No 2 Ltd Compuestos tricíclicos de benzoxaborol y usos de los mismos
MA41495A (fr) * 2015-02-12 2017-12-19 Anacor Pharmaceuticals Inc Composés benzoxaborole et leurs utilisations

Also Published As

Publication number Publication date
WO2015021396A3 (en) 2015-10-29
LT3030519T (lt) 2022-04-11
CR20160064A (es) 2016-06-01
NZ716350A (en) 2022-12-23
JP2019123727A (ja) 2019-07-25
KR20160038901A (ko) 2016-04-07
US20190241586A1 (en) 2019-08-08
HRP20220384T1 (hr) 2022-07-22
CA2919888A1 (en) 2015-02-12
BR112016002651B1 (pt) 2022-11-29
PE20160752A1 (es) 2016-08-17
US10526352B2 (en) 2020-01-07
WO2015021396A2 (en) 2015-02-12
AP2016009046A0 (en) 2016-02-29
PH12016500234B1 (en) 2016-05-16
CN110003253B (zh) 2022-03-18
SG10201914073PA (en) 2020-03-30
MX2016001732A (es) 2016-05-18
CA2919888C (en) 2022-10-18
IL243874B (en) 2018-11-29
SG11201600787PA (en) 2016-03-30
PL3030519T3 (pl) 2022-05-23
US20160251380A1 (en) 2016-09-01
JP2016527321A (ja) 2016-09-08
CN105492388B (zh) 2018-12-21
US10858376B2 (en) 2020-12-08
SA516370551B1 (ar) 2017-10-31
ES2905413T3 (es) 2022-04-08
MY175823A (en) 2020-07-10
PH12016500234A1 (en) 2016-05-16
DOP2016000045A (es) 2016-04-29
ZA201600792B (en) 2022-05-25
AU2017210567B2 (en) 2019-08-01
AU2014305792C1 (en) 2018-07-05
CN105492388A (zh) 2016-04-13
CN110003253A (zh) 2019-07-12
HK1219939A1 (zh) 2017-04-21
US10308668B2 (en) 2019-06-04
US20180044355A1 (en) 2018-02-15
EP4029870A1 (en) 2022-07-20
SI3030519T1 (sl) 2022-04-29
EA201690135A1 (ru) 2016-07-29
PT3030519T (pt) 2022-01-27
EP3030519B1 (en) 2022-01-05
AU2017210567A1 (en) 2017-08-24
EA032844B1 (ru) 2019-07-31
IL243874A0 (en) 2016-04-21
UA116908C2 (uk) 2018-05-25
US20210053999A1 (en) 2021-02-25
JP6764970B2 (ja) 2020-10-07
BR112016002651A2 (pt) 2017-08-01
AU2014305792B2 (en) 2017-05-04
EP3030519A2 (en) 2016-06-15
CY1125030T1 (el) 2023-03-24
DK3030519T3 (da) 2022-01-31
CL2016000313A1 (es) 2016-09-23
EP3030519A4 (en) 2017-03-08
HUE057365T2 (hu) 2022-05-28
WO2015021396A9 (en) 2016-02-11
AU2014305792A1 (en) 2016-03-10
US20200095266A1 (en) 2020-03-26
JP6499175B2 (ja) 2019-04-10
KR102093783B1 (ko) 2020-03-26

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and their uses
HK1248138A1 (zh) 咪唑並吡啶化合物及其用途
HK1226056A1 (zh) 吡唑並化合物及其用途
HK1219939A1 (zh) 三環苯並氧雜硼雜環戊烯化合物及其用途
EP2963027A4 (en) TRICYCLIC CONNECTION AND USE THEREOF
HUE054178T2 (hu) Metil/fluor-piridinil-metoxi-szubsztituált piridinon-piridinil-vegyületek és fluor-pirimidinil-metoxi-szubsztituált piridinon-piridinil-vegyületek
GB201323008D0 (en) Compounds and uses thereof
HK1205545A1 (en) Padlock
GB201321693D0 (en) Composition and uses thereof
GB201312318D0 (en) Novel methods and compounds
GB201300707D0 (en) Compounds and processes
GB201307233D0 (en) Compounds and uses thereof
GB201309180D0 (en) Compounds and Their Uses
HK1223307A1 (zh) 新型化合物和其用途
GB201314610D0 (en) Compounds and their uses
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201306248D0 (en) Compounds and their uses
GB201320161D0 (en) Compounds and their uses
GB201323005D0 (en) Compounds and uses thereof
GB201307202D0 (en) New compounds and uses
GB201307201D0 (en) New compounds and uses
GB201301734D0 (en) New compounds and uses
GB201309248D0 (en) Compounds and combinations
GB201313605D0 (en) Novel compounds and their use
GB201301022D0 (en) Composition and uses thereof